Cited by 107Dermatology and Skin DiseasesLiver Diseases and ImmunityPain Mechanisms and Treatments

Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial

Open access
Bergasa, Nora V., McGee, Monnie, Ginsburg, Iona H., Engler, Danielle·2006·Hepatology

Abstract

Pruritus is defined as the second order of nociception, the first being pain; thus, there is a rationale to study gabapentin, a drug that increases the threshold to experience nociception. The aim of this double-blind, randomized, placebo-controlled trial was to study the effect of gabapentin on the perception of pruritus and its behavioral manifestation, scratching, in cholestasis. The participants were 16 women with chronic liver disease and chronic pruritus. Hourly scratching activity (HSA) was continuously recorded for up to 48 hours at baseline and on treatment for at least 4 weeks in an inpatient setting. The perception of pruritus was assessed by interviews and by a visual analog score (VAS) of pruritus recorded every hour while patients were awake. Patients were randomized to the study drug (gabapentin or placebo) at a starting dose of 300 mg orally per day in divided doses to a maximum of 2,400 mg or until relief from pruritus. Gabapentin was associated with an increase in mean HSA, in contrast to the placebo, which was associated with a decrease. The mean VAS decreased significantly among those taking the placebo and in some patients on gabapentin. In conclusion , gabapentin did not provide a significant therapeutic advantage over the placebo; in fact, it was associated with an increase in the perception of pruritus and in HSA in some patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.21370

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [11]11. Bergasa NV, Alling DW, Talbot TL, Swain MG, Yurdaydin C, Schmitt JM, et al. Naloxone ameliorates the pruritus of cholestasis: results of a double-blind randomized placebo-controlled trial. Ann Intern Med 1995; 123:161-167.

Cited by

Sorted by citations

Authors
Bergasa, N. V., McGee, M., Ginsburg, I. H., & Engler, D.
Affiliations
  • State University of New York (US)
  • Southern Methodist University (US)
  • Columbia University (US)
Corresponding author
Bergasa, Nora V.
Venue
Hepatology
Published
2006-11
Volume
44
Issue
5
Pages
1317-1323
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2136105869
Cited by
107
References
33
Citations by year
2026: 3 · 2025: 2 · 2024: 8 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 2 · 2019: 7 · 2018: 8 · 2017: 6 · 2016: 7 · 2015: 6 · 2014: 2 · 2013: 6 · 2012: 7
FWCI
5.67
Type
journal article
Language
en
Open access
Locations
  • Hepatology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Deutsches Krebsforschungszentrum
  • National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK 55618-01A1)
  • National Center for Research Resources (RR 00645, M01RR000645)
Topics
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
Keywords
gabapentin, pruritus, cholestasis, chronic liver disease, scratching behavior, nociception, antipruritic therapy
MeSH terms
Gabapentin, Adult, Amines, Analgesics, Cholestasis, Chronic Disease, Cyclohexanecarboxylic Acids, Double-Blind Method, Female, gamma-Aminobutyric Acid, Humans, Liver Diseases, Middle Aged, Pain Measurement, Pruritus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review